Skip to main content
European Commission logo print header

Defining regulators of hematopoietic stem cell homing and engraftment

Ziel

Transplantation of hematopoietic stem cells (HSC) is a life-saving treatment for many serious diseases. Unfortunately, the procedure is often hampered by insufficient numbers of donor stem cells and attempts to expand HSCs ex vivo prior to transplantation have remained unsuccessful. An important alternative, which significantly would reduce the required number of donor cells, is to enhance the engraftment efficiency of the transplanted HSCs. The aim of this project is to identify factors that regulate homing and adhesion of HSCs using an RNA interference based screening approach. The principle of the approach is to use lentiviral short-hairpin RNA (shRNA) libraries targeted to HSCs to screen for modifiers of cell adhesion. Adhesive interactions with extracellular matrix and surrounding cells, the so-called niche, are essential for HSC biology. Mesenchymal stroma cells (MSCs) will be used as a model for the adhesive interactions in the hematopoietic niche. When seeded on a layer of MSCs, the vast majority of human HSCs remain adherent to the MSCs. These highly adhesive properties of HSCs constitute a baseline for functional selection of shRNAs interfering with adhesion. Large numbers of HSCs will be targeted with pooled shRNA libraries and candidate shRNAs will be retrieved by functional selection of cells with reduced adhesive properties. The method has been standardized using shRNAs targeting the known mediator of cell adhesion, CD29 (β1 integrin). Knock down of CD29 in HSCs dramatically decreased their adhesion to MSCs. Candidate genes from the screens will be characterized for their role in homing and engraftment of HSCs by assays in vitro as well as in vivo through the ability to repopulate bone marrow of immundeficient NOD/SCID mice. Understanding the basic mechanisms that regulate homing and adhesion of HSCs to their niche is essential in order to develop strategies that may enhance the engraftment process in clinical settings.

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2009-IEF
Andere Projekte für diesen Aufruf anzeigen

Koordinator

MAX IV Laboratory, Lund University
EU-Beitrag
€ 171 828,60
Adresse
Paradisgatan 5c
22100 LUND
Schweden

Auf der Karte ansehen

Region
Södra Sverige Sydsverige Skåne län
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Jens Forsberg (Dr.)
Links
Gesamtkosten
Keine Daten